|  | Meibohm, Bernd (Hrsg.)
Pharmacokinetics and Pharmacodynamics of Biotech Drugs
Principles and Case Studies in Drug Development
 1. Auflage September 2006
179,- Euro
2006. XXII, 404 Seiten, Hardcover
121 Abb., 45 Tab.
- Praktikerbuch -
ISBN 978-3-527-31408-9 - Wiley-VCH, Weinheim
Preis inkl. Mehrwertsteuer zzgl. Versandkosten.
|
Probekapitel
| Jetzt kaufen 
E-Books sind auch über alle bekannten E-Book Shops erhältlich.
|
| Kurzbeschreibung
First ever comprehensive coverage of the pharmacokinetic and pharmacodynamic characteristics of highly important class of biology-based drugs. Spans all topics from lead identification right up to final-stage clinical trials -- a must for all pharmaceutical researchers.
Aus dem Inhalt
The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs
Pharmacokinetics of Peptides and Proteins
Pharmacokinetics of Monoclonal Antibodies
Pharmacokinetics and Pharmacodynamics of Antisense Oligonucleotides
Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors
Bioanalytical Methods used for Pharmacokinetic Evaluations of Biotech Macromolecule Drugs: Issues, Assay Approaches, and Limitations
Limitations of Noncompartmental Pharmacokinetic Analysis of Biotech Drugs
Bioequivalence of Biologics
Biopharmaceutical Challenges in Pulmonary Delivery of Proteins and Peptides
Biopharmaceutical Challenges: Delivery of Oligonucleotides
Custom-Tailored Pharmacokinetics and Pharmacodynamics via Chemical Modifications of Biotech Drugs
Exposure-Response Relationships for Therapeutic Biologic Products
Preclinical and Clinical Drug Development of Tasidotin, a Depsi-Pentapeptide Oncolytic Agent
Clinical Drug Development of Cetuximab, a Monoclonal Antibody
Integration of Pharmacokinetics and Pharmacodynamics into the Drug Development of Pegfilgrastim, a Pegylated Protein
|
|
|
|
